Q3 2025 · 13F-HR
BOONE CAPITAL MANAGEMENT LLCholdings as filed
Filed 2025-11-14 · accession 0001214659-25-016617
$305.0M
Reported value
16
Positions
2025-09-30
Period end
The Brief · BOONE CAPITAL MANAGEMENT LLC · Q3 2025
AI · grounded in 13F
BOONE CAPITAL MANAGEMENT LLC initiated a new position in IONS worth $27.3M. The fund also established new stakes in BBIO for $23.9M and RAPT for $20.2M. To fund these moves, the manager closed positions in AVTR and UNM, reducing exposure by $22.8M and $22.8M respectively. Additionally, the fund increased its holding in CI by 133.07%.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| G5960L103 | MDT | MEDTRONIC PLC | $40.8M | 13.4% | 428,789 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $39.3M | 12.9% | 535,732 | Common | SOLE |
| 462222100 | IONS | IONIS PHARMACEUTICALS INC | $27.3M | 8.96% | 417,833 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $23.9M | 7.84% | 82,972 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $23.9M | 7.84% | 460,282 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $23.4M | 7.66% | 166,414 | Common | SOLE |
| 75382E208 | RAPT | RAPT THERAPEUTICS INC | $20.2M | 6.62% | 782,461 | Common | SOLE |
| 91324P102 | UNH | UNITEDHEALTH GROUP INC | $20.1M | 6.58% | 58,112 | Common | SOLE |
| 09061G101 | BMRN | BIOMARIN PHARMACEUTICAL INC | $17.8M | 5.83% | 328,546 | Common | SOLE |
| G4705A100 | ICLR | ICON PLC | $16.8M | 5.50% | 95,832 | Common | SOLE |
| 19240Q201 | COGT | COGENT BIOSCIENCES INC | $13.6M | 4.45% | 945,042 | Common | SOLE |
| 50015M109 | KOD | KODIAK SCIENCES INC | $11.7M | 3.84% | 715,877 | Common | SOLE |
| G5509L101 | LIVN | LIVANOVA PLC | $8.8M | 2.88% | 167,932 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $8.6M | 2.82% | 147,317 | Common | SOLE |
| 18507C103 | CLPT | CLEARPOINT NEURO INC | $6.2M | 2.03% | 283,912 | Common | SOLE |
| 00289Y206 | ABEO | ABEONA THERAPEUTICS INC | $2.7M | 0.87% | 502,854 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.